Evidence map›Paper›PMID 30675343›Full record

ArticleAntimicrobial resistance and infection control2019

Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey.

Niccolò Buetti, Nasstasja Wassilew, Viktorija Rion, Laurence Senn, Céline Gardiol, Andreas Widmer, Jonas Marschall, for Swissnoso

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Vancomycin-resistant Enterococcus faecium: a national wide genomic snapshot in Switzerland.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2020-2024.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026
    Article
  3. Article
  4. Emergence of vancomycin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  5. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2019-2023.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  6. Article
  7. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2018-2022.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  8. Review
  9. Article
  10. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2017-2021.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023
    Article
  11. Nosocomial outbreak of vancomycin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  12. Article
  13. VanA-Enterococcus faecalis in Poland: hospital population clonal structure and vanA mobilome.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  14. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2016-2020.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Prevalence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Niccolò BuettiDepartment of Infectious Diseases, Bern University Hospital, University of Bern, Freiburgstrasse, 3010 Bern, Switzerland.ORCID 0000-0002-8096-1834
Nasstasja WassilewDepartment of Infectious Diseases, Bern University Hospital, University of Bern, Freiburgstrasse, 3010 Bern, Switzerland.
Viktorija RionSwissnoso, National Center for Infection Control, Bern, Switzerland.
Laurence Senn4Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Céline Gardiol5Swiss Federal Office of Public Health, Bern, Switzerland.
Andreas WidmerDivision of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Jonas MarschallDepartment of Infectious Diseases, Bern University Hospital, University of Bern, Freiburgstrasse, 3010 Bern, Switzerland.
for Swissnoso

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This nation-wide survey on the epidemiology of vancomycin-resistant enterococci (VRE) included 142 healthcare institutions and showed an increasing number of VRE colonizations and infections in Switzerland, probably for the most part due to nosocomial dissemination. The introduction and spread of a new clone, gaps in VRE screening policies as well as heterogeneity regarding the management of VRE clusters may be possible explanations.

Indexed as

Anti-Bacterial AgentsCommunicable Diseases, EmergingGram-Positive Bacterial InfectionsHumansSwitzerlandVancomycinVancomycin ResistanceVancomycin-Resistant EnterococciAnti-Bacterial AgentsVancomycinHospital-acquiredNosocomialOutbreakST796Vancomycin-resistant enterococciVRE

Identifiers

PMID30675343
PMCPMC6337856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.